跳至主要内容
临床试验/NCT03116217
NCT03116217招募中不适用

Multicentre Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves

University Hospital, Toulouse29 个研究点 分布在 9 个国家目标入组 400 人开始时间: 2017年6月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
400
试验地点
29
主要终点
Renal/patient survival at 2 years post-natally.

研究概览

简要总结

Validate the use of fetal urine peptidome-analysis and explore amniotic fluid markers for the stratification of fetuses with Posterior Urethral Valve for post-natal renal function.

详细描述

The ANTENATAL project requires the use of fetal urine as well as post-natal urine, post-natal serum and, possibly, amniotic liquid. We will take an additional tube during the takings collected for routine management of the disease.

The analysis of samples will be carried out in Toulouse at the Institute of Metabolic and Cardiovascular Diseases or with fee-for-service suppliers.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • male singleton fetus with megabladder associated with urinary tract anomalies with or without dysplastic or hyperechogenic parenchyma detected in a first ultrasound;
  • megabladder confirmed in a second ultrasound;
  • collection of fetal urine taken during the routine management of the disease for the dosage of ß2-microglobulin;
  • written informed consent.

排除标准

  • refusal to participate in the study;
  • person protected by law.

结局指标

主要结局

Renal/patient survival at 2 years post-natally.

时间窗: Year 2

Defined by the need for dialysis or death.

次要结局

  • Renal function of the survivors at day 4 and 6 and 12 month post-natally.(Year 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验